Premium
Galectin 9 and PINCH , novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides
Author(s) -
Kawashima Hidenori,
Obayashi Aiko,
Kawamura Marie,
Masaki Sakae,
Tamada Satoshi,
Iguchi Taro,
Uchida Junji,
Kuratsukuri Katsuyuki,
Tanaka Tomoaki,
Nakatani Tatsuya
Publication year - 2014
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12499
Subject(s) - cytotoxic t cell , immunotherapy , antigen , renal cell carcinoma , immunology , biology , peripheral blood mononuclear cell , cancer research , flow cytometry , cancer immunotherapy , tumor antigen , immune system , medicine , pathology , biochemistry , in vitro
Objective To analyse and then generalize the mechanism by which partial or complete response is achieved among a limited number of patients with metastatic renal cell carcinoma ( RCC ) treated with interferon or interleukin‐2.Materials and Methods An expression library of RCC (clear‐cell carcinoma) was screened using the sera of patients with metastatic RCC who benefited from partial or complete response to cytokine therapy, the postulation being that those remarkable responders obtained specific cellular immunity against RCC with the antibodies to react with the cancer antigen. Peripheral blood mononuclear‐cells ( PBMCs ) from healthy volunteers were stimulated with the antigen‐derived peptides to induce specific cytotoxic T lymphocytes ( CTLs ). Specific activities of CTLs were measured by 51 C r‐releasing assay.Results Among 15 positive clones isolated, two novel genes, galectin 9 and PINCH , were expressed at much higher levels in cancerous lesions than in normal tissues in all the patients with clear‐cell carcinoma who were examined. Both HLA ‐ A *2402‐restricted and HLA ‐ A *0201‐restricted CTLs were induced by each antigen‐derived peptide to exhibit specific and highly cytotoxic activities towards RCC cells. Specific CTLs were induced abundantly, as shown by flow cytometry analysis of the CTLs labelled with fluorescein isothiocyanate anti‐ CD 107a and APC anti‐ CD 8. The clonal expansion of the CTLs was shown by the clonality of T ‐cell receptor V β repertoires.Conclusion A novel approach based on clinical observations yielded promising tumour antigens as immunotherapy targets of RCC .